Sigma Healthcare Earnings: Rising Demand for Weight-Loss Drugs to Support Another Strong Year
Sigma's revenue grew by 16% to AUD 10.9 billion in fiscal 2026, on a pro-forma basis. The core Chemist Warehouse network in Australia benefited from strong demand for weight loss drugs. Underlying EBIT increased by 21%, but shares fell 8% as the growth was still less than the market expected.